"This is a good speculative stock." said Cramer about the clinical contract research company providing late phase clinical development services to the biotechnology, pharmaceutical and the medical device industries.
More from Investing
The key issue in a better market is to put more money to work and have more exposure.
Outside of the ETF launch which could generate flow into the crypto space, it is important to ask what the real theme is for Bitcoin.
Let's see if this is the time to step on the accelerator.